EXECUTIVE ENGAGEMENTS
POOL
2632
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
473
Interactions with Platform & by Email
PARTICIPANTS
79
Unique # Participated
VALIDATIONS
23
Responses Validated*
COMPANIES
17
Responses Validated*
* Login for a full stack data experience
DATE
OCT 2022
TABLES
123
PAGES
182
EDITION
8
PRICE
USD 5450
CODE
MCP13532
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
What's New for 2022?
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Global High-flow Nasal Cannula Market to Reach $3.7 Billion by 2027
In the changed post COVID-19 business landscape, the global market for High-flow Nasal Cannula estimated at US$2.5 Billion in the year 2020, is projected to reach a revised size of US$3.7 Billion by 2027, growing at aCAGR of 5.3% over the period 2020-2027. Plastic, one of the segments analyzed in the report, is projected to record 5.3% CAGR and reach US$3.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Silicone segment is readjusted to a revised 5.8% CAGR for the next 7-year period.
The U.S. Market is Estimated at $686.8 Million, While China is Forecast to Grow at 8.7% CAGR
The High-flow Nasal Cannula market in the U.S. is estimated at US$686.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$789.2 Million by the year 2027 trailing a CAGR of 8.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 4.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.
SELECT PLAYERS
Becton, Dickinson and Company; Fisher & Paykel Healthcare Corporation Ltd.; Flexicare Medical Ltd.; Great Group Medical Co., Ltd.; Hamilton Medical AG; MEK-ICS Co., Ltd.; Resmed Inc.; Salter Labs Inc.; Smiths Medical; Teijin Pharma Ltd.; Teleflex, Inc.; TNI Medical AG; Vapotherm, Inc.
SEGMENTS
» Material (Plastic, Silicone) » Application (Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis, Other Applications) » End-Use (Hospitals, Long Term Care Centers, Ambulatory Surgery Centers, Other End-Uses)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| High-flow Nasal Cannula – Global Key Competitors Percentage Market Share in 2022 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Recent Past, Current & Future Analysis for Acute Respiratory Failure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Acute Respiratory Failure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Acute Respiratory Failure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Acute Heart Failure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Acute Heart Failure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Acute Heart Failure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Carbon Monoxide Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Carbon Monoxide Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Carbon Monoxide Toxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Sleep Apnea by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Sleep Apnea by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Sleep Apnea by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Bronchiectasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Bronchiectasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Bronchiectasis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World High-flow Nasal Cannula Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027 |
| World Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for High-flow Nasal Cannula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for High-flow Nasal Cannula by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Plastic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Plastic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Plastic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Silicone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Silicone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Silicone by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Long Term Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Long Term Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Long Term Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| High-flow Nasal Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
| USA Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| USA Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| USA Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Canada Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Canada Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| JAPAN |
| High-flow Nasal Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
| Japan Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Japan Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Japan Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| CHINA |
| High-flow Nasal Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
| China Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| China Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| China Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| EUROPE |
| High-flow Nasal Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
| Europe Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for High-flow Nasal Cannula by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for High-flow Nasal Cannula by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| FRANCE |
| High-flow Nasal Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
| France Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| France Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| France Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| GERMANY |
| High-flow Nasal Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
| Germany Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Germany Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Germany Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Italy Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Italy Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| UNITED KINGDOM |
| High-flow Nasal Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
| UK Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| UK Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| UK Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| SPAIN |
| Spain Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Spain Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Spain Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| RUSSIA |
| Russia Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Russia Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Russia Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Rest of Europe Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Rest of Europe Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| ASIA-PACIFIC |
| High-flow Nasal Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for High-flow Nasal Cannula by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for High-flow Nasal Cannula by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| AUSTRALIA |
| High-flow Nasal Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E) |
| Australia Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Australia Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Australia Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| INDIA |
| High-flow Nasal Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E) |
| India Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| India Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| India Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| SOUTH KOREA |
| South Korea Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| South Korea Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| South Korea Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| LATIN AMERICA |
| High-flow Nasal Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E) |
| Latin America Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Latin America Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for High-flow Nasal Cannula by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for High-flow Nasal Cannula by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027 |
| Latin America Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Latin America Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| ARGENTINA |
| Argentina Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Argentina Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Argentina Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| BRAZIL |
| Brazil Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Brazil Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Brazil Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| MEXICO |
| Mexico Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Mexico Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Mexico Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| REST OF LATIN AMERICA |
| Rest of Latin America Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Rest of Latin America Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Rest of Latin America Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| MIDDLE EAST |
| High-flow Nasal Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E) |
| Middle East Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Middle East Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for High-flow Nasal Cannula by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for High-flow Nasal Cannula by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027 |
| Middle East Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Middle East Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| IRAN |
| Iran Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Iran Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Iran Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| ISRAEL |
| Israel Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Israel Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Israel Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| SAUDI ARABIA |
| Saudi Arabia Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Saudi Arabia Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Saudi Arabia Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| UNITED ARAB EMIRATES |
| UAE Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| UAE Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| UAE Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| REST OF MIDDLE EAST |
| Rest of Middle East Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Rest of Middle East Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Rest of Middle East Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| AFRICA |
| High-flow Nasal Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E) |
| Africa Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for High-flow Nasal Cannula by Application - Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for High-flow Nasal Cannula by Application - Percentage Breakdown of Value Sales for Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Acute Heart Failure, Sleep Apnea, Carbon Monoxide Toxicity, Bronchiectasis and Other Applications for the Years 2012, 2021 & 2027 |
| Africa Recent Past, Current & Future Analysis for High-flow Nasal Cannula by Material - Plastic and Silicone - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for High-flow Nasal Cannula by Material - Plastic and Silicone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for High-flow Nasal Cannula by Material - Percentage Breakdown of Value Sales for Plastic and Silicone for the Years 2012, 2021 & 2027 |
| Africa Recent Past, Current & Future Analysis for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for High-flow Nasal Cannula by End-Use - Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for High-flow Nasal Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long Term Care Centers, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
| IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com